People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Healthtech, Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aledade, Inc. | — | Healthtech | Series D+ | $662.6M | $3.5B | 2016 |
| eGenesis, Inc. | — | Biotechnology | Series D+ | $265.0M | $316.7M | 2019 |
| Compass Therapeutics, Inc. | — | Pharma | Series D+ | $255.8M | $2.1B | 2020 |
| Variant Bio, Inc. | — | Biotechnology | Series D+ | $127.7M | $2.8B | 2020 |
| Guide Therapeutics, Inc. | — | Pharma | Series A | $13.9M | $173.6M | 2019 |
Julie Sunderland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Julie Sunderland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bob More | 2 | 6 |
| Steven Gillis | 1 | 23 |
| Andrew Perlman | 1 | 15 |
| Adam Goulburn | 1 | 10 |
| Stuart Nagae | 1 | 9 |
| Josh Wolfe | 1 | 8 |
| PAUL SEKHRI | 1 | 7 |
| CARL L. GORDON | 1 | 7 |
| Philip J. Ferneau | 1 | 6 |
| Brad Smith | 1 | 6 |
| Lucio Iannone | 1 | 6 |
| PATRICK CONWAY | 1 | 6 |
| Isaac Ciechanover | 1 | 5 |
| Robert Kocher | 1 | 5 |
| Geoff MacKay | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Elena Viboch | 1 | 4 |
| Sapna Srivastava | 1 | 3 |
| Boris Nikolic | 1 | 3 |
| Mark McClellan | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.